Prognosis
Biggest Vaccine Maker’s Problems Keep World Short of Covid Shots
- Emerging nations scramble for vaccines amid Serum’s struggles
- Serum has cited external problems such as India export curbs
This article is for subscribers only.
Around the world, from Bangladesh to Nepal to Rwanda, vulnerable hotspots have been grappling with stalled Covid-19 vaccination programs as they run out of doses. Many of those shortages can be traced back to a single company: The Serum Institute of India.
The world’s largest vaccine maker, Serum was last year named a top supplier of Covid shots to Covax, the World Health Organization-backed initiative aimed at securing an equitable global rollout. But the Indian company has been dogged by setbacks, from a ban on exports to a factory fire, that have hampered its ability to fill orders.